Literature DB >> 3143274

Successful GnRH treatment in a patient with Kallmann's syndrome, who previously failed HMG/HCG treatment.

M Berezin1, R Weissenberg, O Rabinovitch, B Lunenfeld.   

Abstract

A successful GnRH treatment for hypogonadotropic hypogonadism is described. A 40 year old infertile patient due to Kallmann's syndrome, associated with obesity and NIDDM, was treated with HCG (5,000 IU/week) for 8 years. In an attempt to induce spermatogenesis HMG (75 IU/daily) was added for 2 years. During the combined gonadotropin treatment semen analysis indicated an improvement from azoospermia to 2 x 10(6) sperm/ml. Since semen quality remained poor and obviously no pregnancy was achieved, the last regime was replaced by a pulsatile GnRH treatment (5 mcg/90 minutes). Following 6 months sperm count increased up to 15 x 10(6) associated with normal motility and morphology. Patient's wife conceived after the second intrauterine insemination and delivered a full term healthy baby.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3143274     DOI: 10.1111/j.1439-0272.1988.tb00687.x

Source DB:  PubMed          Journal:  Andrologia        ISSN: 0303-4569            Impact factor:   2.775


  1 in total

1.  Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism.

Authors:  Jiang-Feng Mao; Zhao-Xiang Liu; Min Nie; Xi Wang; Hong-Li Xu; Bing-Kun Huang; Jun-Jie Zheng; Le Min; Ursula Brigitte Kaiser; Xue-Yan Wu
Journal:  Asian J Androl       Date:  2017 Nov-Dec       Impact factor: 3.285

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.